Straits Times Index
3,401.84 -8.97 (-0.26%) Nikkei
40,780.70 -131.67 (-0.32%) Hang Seng
17,481.75 -317.86 (-1.79%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
55,350.75 -2,342.21 (-4.06%) CMC Crypto 200
1,151.98 -14.13 (-1.21%)
PTGX Aug 2024 30.000 call
| Previous close | 4.5000 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 30.00 |
| Expiry date | 2024-08-16 |
| Day's range | 4.5000 - 4.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
PR NewswireProtagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
Insider MonkeyIs Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
Simply Wall St.We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation
Key Insights Protagonist Therapeutics to hold its Annual General Meeting on 20th of June Salary of US$655.2k is part of...
